Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mala S Sivanandy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|March 11, 2023
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary SyndromeMala S Sivanandy, Sierra K Ha
Journal of Clinical Medicine|February 24, 2024
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A ReviewRachel Porth, Karina Oelerich, Mala S Sivanandy
Cleveland Clinic Journal of Medicine|March 23, 2007
Update on hormonal contraceptionNziavake Masimasi, Mala S Sivanandy, Holly L Thacker
Biomedicines|January 25, 2025
The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsElham Razmpoosh, Mala S Sivanandy, Alan M Ehrlich
Cleveland Clinic Journal of Medicine|May 18, 2007
Newer hormonal therapies: lower doses; oral, transdermal, and vaginal formulationsMala S Sivanandy, Nziavake Masimasi, Holly L Thacker
Diabetes Care|January 28, 2009
Exenatide-associated ischemic renal failureWolfgang J Weise, Mala S Sivanandy, Clay A Block, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|March 11, 2023
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary SyndromeMala S Sivanandy, Sierra K Ha
Journal of Clinical Medicine|February 24, 2024
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A ReviewRachel Porth, Karina Oelerich, Mala S Sivanandy
Cleveland Clinic Journal of Medicine|March 23, 2007
Update on hormonal contraceptionNziavake Masimasi, Mala S Sivanandy, Holly L Thacker
Biomedicines|January 25, 2025
The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsElham Razmpoosh, Mala S Sivanandy, Alan M Ehrlich
Cleveland Clinic Journal of Medicine|May 18, 2007
Newer hormonal therapies: lower doses; oral, transdermal, and vaginal formulationsMala S Sivanandy, Nziavake Masimasi, Holly L Thacker
Diabetes Care|January 28, 2009
Exenatide-associated ischemic renal failureWolfgang J Weise, Mala S Sivanandy, Clay A Block, et al.
Pageof 1